{"id":563073,"title":"Draft guidance document: Generic drug equivalence: Medicinal ingredients  - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-02-16","captureTimestamp":"2026-02-16T11:37:38.741000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-consultations/drug-products/consultation-profile-draft-generic-drug-equivalence/document-1.html","snippet":"Draft Guidance Document: Generic Drug Equivalence: Medicinal Ingredients This guidance document is being distributed for comment purposes only. Draft Date: 2019/04/08 Download the alternative format (PDF format, KB, pages) Foreword Guidance documents are meant to provide…","rawSnapshotUrl":"/api/snapshots/raw/563073","browseUrl":"https://replay.healtharchive.ca/job-6/20260216113738/https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-consultations/drug-products/consultation-profile-draft-generic-drug-equivalence/document-1.html#ha_snapshot=563073","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}